Fate Therapeutics, Inc. FATE
1.01 USD -0.04 (-3.81%)
Regular-session close
1.05 +0.04 +3.79%
After hours · Nov 19, 7:13 PM ET
1.01 Day range 1.07
0.95 52-week range 3.23
- YTD
- +3.06%
- 1 year
- -3.81%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 6.65M | 13.63M | 63.53M | 96.30M | 55.85M | |
| 6.65M | 13.63M | 63.53M | 96.30M | 55.85M | |
| 6.65M | 13.63M | 63.53M | 96.30M | 55.85M | |
| 154.35M | 223.91M | 254.04M | 404.69M | 272.84M | |
| 107.83M | 135.00M | 172.60M | 320.45M | 215.52M | |
| 46.52M | 74.17M | 81.45M | 84.23M | 57.32M | |
| -147.70M | -210.28M | -190.51M | -308.39M | -216.99M | |
| -136.31M | -186.26M | -160.93M | -281.72M | -212.15M | |
| -136.31M | -186.26M | -160.93M | -281.72M | -212.15M | |
| -136.31M | -186.26M | -160.93M | -281.72M | -212.15M | |
| -136.31M | -186.26M | -160.93M | -281.72M | -212.15M | |
| -1.15 | -1.64 | -1.64 | -2.91 | -2.24 | |
| -1.15 | -1.64 | -1.64 | -2.91 | -2.24 | |
| -1.15 | -1.64 | -1.64 | -2.91 | -2.24 | |
| -136.31M | -186.26M | -160.93M | -281.72M | -212.15M | |
| -136.31M | -186.26M | -160.93M | -281.72M | -212.15M | |
| 118.79M | 113.69M | 98.41M | 96.83M | 94.75M | |
| 118.79M | 113.69M | 98.41M | 96.83M | 94.75M |
